Literature DB >> 2890672

Prediction of neuroleptic-induced dystonia.

G A Keepers1, D E Casey.   

Abstract

For patients receiving neuroleptics, age, sex, neuroleptic potency, and dose all influence the likelihood of a dystonic reaction. Little is known, however, of the relative importance of these factors or of the feasibility of predicting dystonia in individual patients. We reviewed 135 charts of psychotic inpatients to examine these factors and their usefulness in predicting dystonia. Age, sex, neuroleptic type, dose, and occurrence of dystonia were recorded for the first 4 days of drug treatment and were used to construct a linear discriminant function that classified the cases as to whether dystonia was expected. Internal cross-validation was performed, and the error rate of this classification procedure was calculated. Forty-nine (36%) of the patients had dystonia. A younger age was the most powerful predictor of dystonia. Male gender was second in predictive power with minor effects from neuroleptic dose and potency. The overall error rate (false-positive and false-negative errors combined) of the discriminant function was 30%. These results suggest the possibility of predicting dystonia in individual patients but should be regarded with caution since the predictive procedure has not been tested prospectively. If confirmed, these data may allow treatment strategies that protect patients from dystonia while sparing patients not at risk unnecessary treatment with antiparkinson agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890672

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  12 in total

Review 1.  Acute dystonia induced by drug treatment.

Authors:  P N van Harten; H W Hoek; R S Kahn
Journal:  BMJ       Date:  1999-09-04

2.  Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Authors:  Stanley N Caroff; Irene Hurford; Janice Lybrand; E Cabrina Campbell
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

3.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia.

Authors:  M F Bristow; S R Hirsch
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 5.  Clozapine: neuroleptic-induced EPS and tardive dyskinesia.

Authors:  D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register.

Authors:  Ehtesham Iqbal; Robbie Mallah; Richard George Jackson; Michael Ball; Zina M Ibrahim; Matthew Broadbent; Olubanke Dzahini; Robert Stewart; Caroline Johnston; Richard J B Dobson
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

7.  Dopamine receptor and Gα(olf) expression in DYT1 dystonia mouse models during postnatal development.

Authors:  Lin Zhang; Deirdre M McCarthy; Nutan Sharma; Pradeep G Bhide
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 8.  Spotlight on Oculogyric Crisis: A Review.

Authors:  Pankaj Mahal; Navratan Suthar; Naresh Nebhinani
Journal:  Indian J Psychol Med       Date:  2020-09-03

9.  Acute dystonia after using single dose duloxetine: case report.

Authors:  Görkem Karakaş Uğurlu; Sinay Onen; Deniz Bayındırlı; Ali Cayköylü
Journal:  Psychiatry Investig       Date:  2013-02-08       Impact factor: 2.505

Review 10.  Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.

Authors:  Robert A Hauser; Jonathan M Meyer; Stewart A Factor; Cynthia L Comella; Caroline M Tanner; Rose Mary Xavier; Stanley N Caroff; Leslie Lundt
Journal:  CNS Spectr       Date:  2020-11-20       Impact factor: 4.604

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.